N-Acetyl Semax Amidate
Stabilized Semax analog with longer duration.
What it is
N-Acetyl Semax Amidate (NA-Semax-Amidate) is a stabilized analog of Semax with N-acetylation at the N-terminus and amidation at the C-terminus. These structural modifications are intended to extend the peptide’s half-life and biological activity compared to standard Semax.
The compound is more recently developed than standard Semax and has substantially less clinical research. Most clinical use is based on extrapolation from Semax research with the hypothesis that the stabilized analog provides longer-lasting effects.
Mechanism of action
Same proposed mechanisms as standard Semax: BDNF/NGF upregulation, dopaminergic and cholinergic effects, neuroprotective and cognitive effects. The structural modifications affect pharmacokinetics rather than fundamental pharmacology.
Clinical evidence
The clinical research base on NA-Semax-Amidate specifically is limited. Most evidence supporting use comes from extrapolation from the substantial Russian clinical literature on standard Semax.
Why we don’t prescribe it at The Tide
For cognitive support indications, we prescribe standard Semax based on its substantial Russian clinical evidence base. The stabilized analog represents an unvalidated extrapolation. The Russian clinical research and approval was conducted with the standard Semax formulation; whether the stabilized analog produces equivalent or improved clinical outcomes is empirically untested. We prefer to use the version with established evidence.
Side effects and contraindications
Limited specific safety data. Likely similar to standard Semax. Avoided in pregnancy, breastfeeding, and significant psychiatric conditions where psychiatric care is appropriate.